Cytek Biosciences, Inc. (CTKB) vs Pacific Biosciences of California, Inc. (PACB)
- Cytek Biosciences, Inc. CTKB 5.24 −3.14%
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
Cytek Biosciences, Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Cytek Biosciences, Inc. is the larger, with a market value of $703.2M against $609.2M — 1.2× the size. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.44% against 2.02%. Cytek Biosciences, Inc. has the higher net margin (−39.0% vs −82.5%) and the lower return on invested capital (−46.4% vs −22.2%). Across the 17 metrics below, Cytek Biosciences, Inc. leads on 11 and Pacific Biosciences of California, Inc. on 6.
Valuation
Profitability
| Metric | CTKB | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 53.23% | 36.38% | 56.01% |
| Operating margin | (21.60%) | (83.53%) | (15.03%) |
| Net margin | (38.98%) | (82.49%) | (20.40%) |
| Free cash flow margin | (5.79%) | (50.53%) | (7.24%) |
| Return on equity | (23.04%) | (929.31%) | (15.32%) |
| Return on assets | (17.14%) | (16.66%) | (19.72%) |
| Return on invested capital | (46.36%) | (22.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack